Sedating antihistamine treatment with promethazine in patients with severe COPD with and without asthma: death and severe exacerbations in a nationwide register study

BACKGROUND: Sedating antihistamines such as promethazine are used as anxiolytics and hypnotic agents for patients with chronic obstructive pulmonary disease (COPD) with and without asthma despite limited knowledge of its effects and side effects. We evaluated if treatment with promethazine had a low...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnesen, Barbara, Rømer, Valdemar, Graff Jensen, Sidse, Wilcke, Jon Torgny, Janner, Julie, Bak, Jens, Johansson, Sofie, Laursen, Christian B., Pedersen, Lars, Eklof, Josefin, Sivapalan, Pradeesh, Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481760/
https://www.ncbi.nlm.nih.gov/pubmed/37680536
http://dx.doi.org/10.1080/20018525.2023.2250604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481760/
https://www.ncbi.nlm.nih.gov/pubmed/37680536
http://dx.doi.org/10.1080/20018525.2023.2250604

Ejemplares similares